STERIS is a global leader in infection prevention, contamination control, surgical technologies, and more.
STERIS is the world’s pre-eminent infection prevention, decontamination, and surgical and critical care company, with a long list of first-to-market products and industry-leading service innovations and thousands of customers in more than 60 countries.
While the corporation was founded as Innovative Medical Technologies in 1985 and renamed STERIS in 1987, our history dates back to 1894 with the founding of American Sterilizer Company, a long-time, global leading innovator of sterilization products.
Today, through a series of strategic acquisitions and continual innovation of new products, STERIS holds one of the broadest portfolios of products in the industry. It stands at the forefront of efforts to prevent infection and contamination in healthcare and pharmaceutical environments, and is broadening its reach with products to meet the needs of defense and industrial markets.

Type
Public
HQ
Mentor, US
Founded
1987
Size (employees)
14,000 (est)
Website
steris.com
STERIS was founded in 1987 and is headquartered in Mentor, US

STERIS Office Locations

STERIS has an office in Mentor
Mentor, US (HQ)
5960 Heisley Rd
Mentor, US
9260 Progress Pkwy

STERIS Data and Metrics

STERIS Financial Metrics

STERIS's revenue was reported to be $2.2 b in FY, 2016 which is a 21% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

2.2 b

Revenue growth (FY, 2015 - FY, 2016), %

21%

Gross profit (FY, 2016)

895.5 m

Gross profit margin (FY, 2016), %

40%

Net income (FY, 2016)

110.8 m

EBIT (FY, 2016)

212.9 m

Market capitalization (26-May-2017)

6.6 b

Closing share price (26-May-2017)

77.4

Cash (31-Dec-2016)

248.8 m
STERIS's current market capitalization is $6.6 b.
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Revenue

1.6 b1.9 b2.2 b

Revenue growth, %

14%21%

Cost of goods sold

972.6 m1.1 b1.3 b

Gross profit

649.6 m774.3 m895.5 m

Gross profit Margin, %

40%42%40%

R&D expense

48.6 m54.1 m56.7 m

Operating expense total

442.8 m547.1 m682.6 m

EBIT

206.8 m227.2 m212.9 m

EBIT margin, %

13%12%10%

Interest expense

18.8 m19.2 m42.7 m

Income tax expense

58.9 m73.8 m60.3 m

Net Income

129.4 m135.1 m110.8 m
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Cash

152.8 m167.7 m248.8 m

Accounts Receivable

313.7 m325.3 m471.5 m

Inventories

37 m35 m59.4 m

Current Assets

674.7 m720.4 m972.5 m

PP&E

454.4 m493.1 m1.1 b

Total Assets

1.9 b2.1 b5.3 b

Accounts Payable

102.4 m99.3 m139.6 m

Current Liabilities

254.5 m283.3 m400.6 m

Retained Earnings

1.1 b1.2 b939.5 m

Total Equity

1 b1.1 b3 b

Financial Leverage

1.8 x2 x1.8 x
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Net Income

129.4 m135.1 m110.8 m

Accounts Receivable

(29 m)(2.8 m)(31.6 m)

Accounts Payable

19.4 m(3.1 m)5.2 m

Cash From Operating Activities

209.6 m246 m81.2 m

Cash From Investing Activities

(148.7 m)(283.8 m)(729.6 m)

Long-term Borrowings

(70 m)(92.6 m)

Cash From Financing Activities

(54.2 m)69.8 m560.3 m
Numbers are in $, USDY, 2016

Revenue/Employee

729.5 k

Financial Leverage

1.8 x

STERIS Operating Metrics

FY, 2016

Patents (foreign)

1.1 k

Patents (US)

390

Patents Pending

470

STERIS Market Value History

STERIS Revenue Breakdown

STERIS Median Salaries

Source: 46 public H-1B filings from STERIS

STERIS Online and Social Media Presence

STERIS Company Life and Culture

You may also be interested in